1. Introduction {#sec1}
===============

Diabetic retinopathy (DR) is one of the severe complications of diabetes leading to loss of vision. Although the pathogenic mechanism of DR has been investigated for many years and a number of theories have been proposed \[[@B1], [@B2]\], the mechanism of DR remains unknown and needs further exploration.

Some diabetic patients are susceptible to DR, while others are quite resistant or develop minimal pathological changes \[[@B3]\]. It may be supposed that such DR-resistant patients are protected genetically. The existence of a DR-resistant gene was proposed, and a comparative study was performed of the gene expression between susceptible and resistant DR patients \[[@B4]\]. It was found that many endoplasmic reticulum (ER) stress-related factors are highly expressed in non-DR diabetic patients.

In our earlier work, we found that P58^IPK^/DNAJC3, an ER stress-related factor, binds to the ER transmembrane protein PERK (protein kinase RNA-activated- (PKR-) like ER kinase), which is normally activated by the ER stress/unfolded protein response. By binding to PERK, P58^IPK^ thereby inhibits its phosphorylation of the *α*-subunit of eukaryotic translation initiation factor 2 (eIF-2*α*) and thus compromises eIF2/EIF2S3\'s mediator role in the translation of mRNA \[[@B5]\]. In this way, P58^IPK^ inhibits ER stress in the endothelial cells of human retinal vessels. P58^IPK^ also downregulates the expression of vascular endothelial growth factor (VEGF), which is associated with regulation of the pathology of DR \[[@B6]\]. VEGF plays a key role in DR \[[@B7], [@B8]\] and is regulated at the transcriptional level by the unfolded protein response pathway \[[@B9]\]. Recent reports also show that ER stress plays an important role in DR \[[@B10], [@B11]\]. Li et al. \[[@B12]\] demonstrated that multiple ER stress markers, including 78 kDa glucose-regulated protein (GRP78), phosphoinositol-requiring transmembrane kinase (IRE)1*α*, and phosphor-eIF2*α* were significantly upregulated in the retinas of animal models of type 1 diabetes and oxygen-induced retinopathy. Our recent work suggests that early progression of DR may be mediated by ER stress, but probably does not involve changes in activating transcription factor (ATF)4 or GRP78 \[[@B13]\]. Together, these studies suggest that although ER stress is involved in the development of DR, its specific pathogenesis is not yet understood.

ER stress is a complicated process involving a network of signaling pathways and hundreds of factors that function by triggering the PERK, IRE1 and ATF6 signaling pathways \[[@B14]--[@B16]\]. In order to delve into the effects of these ER stress-related factors on DR, we classified them into 11 categories according to function ([Figure 1](#fig1){ref-type="fig"}, [Table 3](#tab3){ref-type="table"}), based on Jonikas et al. \[[@B17]\]. We selected 89 ER stress factors from more than 200, based on our work and that of others ([Table 4](#tab4){ref-type="table"}) \[[@B13], [@B17]--[@B21]\]. These factors contain the 11 categories of ER stress. Expression of these factors in the retinas of diabetic rats was determined by quantitative real-time PCR (Q-PCR) arrays to find the specific factors and the ER stress signaling pathways that may play a key role in the pathogenesis of DR.

2. Methods {#sec2}
==========

2.1. Diabetic Rat Model {#sec2.1}
-----------------------

Two-month-old male Sprague Dawley rats weighing 150 to 200 g were obtained from the animal center of Huazhong University of Science and Technology. Care, use, and treatment of animals were approved by the laboratory animal center of Huazhong University of Science and Technology. Rats were randomly divided into diabetic and control groups (*n* = 30 per group). The diabetic model was created by intraperitoneal injection of a single dose of streptozotocin (STZ; 65 mg/kg in 0.01 M citrate buffer, pH 4.5) \[[@B22]\]. Nondiabetic rats (the control group) were injected with citrate buffer only. Fasting plasma glucose was examined 3 d after STZ injection, and diabetes was confirmed by a value ≥16.7 mmol/L using Touch Glucometer (Boehringer Mannheim Diagnostics, Indianapolis, IN). Our previous work \[[@B13]\] and that of others \[[@B23]\] have established that in the STZ-induced diabetes model, diabetic retinopathy develops within one month of the development of diabetes. Accordingly, one and three months after the STZ injection, the retinas were separated from the eyes of both the diabetic and control groups. RNA was extracted and assessed using Q-PCR arrays, with 9 rats in each group.

2.2. Quantitative Real-Time RNA Polymerase Chain Reaction (Q-PCR) Arrays {#sec2.2}
------------------------------------------------------------------------

The mRNA levels of 96 factors (89 ER stress-related factors and 7 quality control factors) were measured using Q-PCR arrays. Total RNA was extracted from rat retinal tissue using Trizol reagent (Invitrogen, Carlsbad, USA) according to the manufacturer\'s instructions. RNA was treated with DNAase (Invitrogen, Carlsbad, USA) and purified using Rneasy MinElute Clean-up Kit (Quiagen, Hilden, Germany). The cDNA was then synthesized using a SuperScript III kit (Invitrogen, Carlsbad, USA). Removing the plate seal from the PCR Array (SABioscience, Frederick, USA) and adding the cocktails to the PCR Array, Q-PCR was performed by using the Hot Star polymerase kit (Qiagen, Venlo, The Netherlands) with SYBR Green technology (ABI, Tampa, FL). PCR reaction buffer was added to a 384-well PCR array plate which was then tightly sealed with an optical adhesive cover. The thermocycling program consisted of 95°C for 10 min, then 40 cycles at 95°C for 15 s, and 60°C for one minute, then compared the differential expression of gene between the two groups.

2.3. Immunofluorescence {#sec2.3}
-----------------------

Immunofluorescence was performed on 5 *μ*m frozen sections. Briefly, retinal sections were incubated with a rabbit anti-HERP (Santa Cruz Biotechnology, Santa Cruz, Calif) or anti-Hrd1 (Biosynthesis Biotechnology, Beijing, China) antibody (1 : 200) at 4°C overnight. This was followed by the secondary antibody, fluorescein-conjugated goat antirabbit IgG (Antigene, Wu Han, China), for one hour. The slides were visualized and photographed under a fluorescence microscope (Olympus, Hamburg, Germany).

2.4. Western Blot {#sec2.4}
-----------------

Total protein was extracted from rat retinal tissue in 300 *μ*L lysis buffer (50 mM Tris pH 7.5, 0.5 M NaCl, 1% NP-40, 1% sodium deoxycholate monohydrate, 2 mM EDTA, and 0.1% SDS). After centrifugation at 1000 ×g for 3 min, protein extracts were diluted with sample buffer (126 mM Tris HCl pH 6.8, containing 20% glycerol, 4% SDS, 0.005% bromophenol blue, and 5% 2-mercaptoethanol) at a 1 : 1 ratio and boiled for 3 minutes. The samples were fractionated according to size on a 12.5% SDS-polyacrylamide gel, transferred to a nitrocellulose membrane (Millipore, Billerica, Mass), and probed with polyclonal anti-HERP (Santa Cruz Biotechnology, Santa Cruz, Calif) or polyclonal anti-Hrd1 (Biosynthesis Biotechnology, Beijing, China) antibodies. A secondary antibody, goat antirabbit IgG (Biosynthesis Biotechnology, Beijing, China) diluted 1 : 1000, was applied, and the chemiluminescent signal was detected. The same membrane was reused to detect *β*-actin (the internal control) by incubating it with mouse antihuman *β*-actin antibody (Gene, Hong Kong, China). Bands observed on the photography films were analyzed by automatic image analysis. The integrated optical density of each protein band was normalized to that of the corresponding *β*-actin band from the same sample.

2.5. Rat Retinal Capillary Endothelial Cell (RRCEC) Culture {#sec2.5}
-----------------------------------------------------------

RRCECs cultured *in vitro* were prepared as previously described \[[@B24]\]. Two-month-old male Sprague Dawley rats weighing 150--200 g (*n* = 60) were obtained from the animal center of Huazhong University of Science and Technology. After anesthesia, the eyes were removed, and the retinas harvested and homogenized by two gentle up-and-down strokes in a 15 mL homogenizer (Dounce; Bellco Glass, Vineland, NJ). The homogenate was filtered through an 88 *μ*m sieve. The retentate was digested in 0.066% collagenase for 45 min at 37°C. The homogenate was centrifuged (1000 ×g for 10 min), and the pellet was resuspended in endothelial basal growth medium (Invitrogen-Gibco, Grand Island, NY), supplemented with 20% fetal bovine serum, 50 U/mL endothelial cell growth factor (Sigma-Aldrich, St. Louis, Mo), and 1% insulin-transferrin-selenium. RRCECs were cultured in fibronectin-coated dishes and incubated at 37°C in a humidified atmosphere containing 5% CO~2~.

Cultured endothelial cells were characterized by evaluating expression of factor VIII antigen (von Willebrand factor) and determining unchanged morphology under culture conditions by light microscopy. The expression of acetyl-LDL (Ac-LDL) receptors in endothelial cells was measured by adding fluorescence-labeled AC-LDL (Biomedical Technologies, Palatine, Il). Only cells from passages 3 to 7 were used in the experiments.

2.6. Cell Immunofluorescence {#sec2.6}
----------------------------

The RRCECs were grown in 24-well plates in human endothelial serum-free material basal growth medium containing 8.3 mM glucose. Upon attaining 80%, confluency cells were treated with medium containing 25 mM glucose for 2 d. Cells were then fixed with 4% formaldehyde for 15 min and permeabilized in 0.1% Triton X-100 for 10 min. Cells were incubated with primary antibody at 4°C overnight followed by secondary antibody for one hour. The slides were visualized and photographed under a fluorescence microscope (Olympus, Hamburg, Germany).

2.7. Statistical Analysis {#sec2.7}
-------------------------

Normally distributed data were compared using Student\'s independent samples *t*-test or one-way ANOVA where appropriate. When a significant difference was detected between groups, multiple comparisons of means were performed using the Bonferroni procedure, with type-I error rate at a maximum of 0.017 (0.05/3) adjustment. Statistical analyses were performed using Statistical Package for the Social Sciences (SPSS) 15.0 software (SPSS, Chicago, IL). Data were presented as the mean ± standard deviation (SD). A probability (*P*) value \<0.05 was considered statistically significant.

3. Results {#sec3}
==========

3.1. Q-PCR Arrays {#sec3.1}
-----------------

We detected 89 ER stress-related genes and found that the mRNA levels of 13 genes in the diabetic rats changed significantly during the first month ([Table 1](#tab1){ref-type="table"}). We found that in the third month the levels of expression of 12 genes were changed significantly in these diabetic rats ([Table 2](#tab2){ref-type="table"}). The changes in the expression levels of genes corresponded to 8 and 10 categories of signal pathways in the first and third months, respectively ([Figure 1](#fig1){ref-type="fig"} and [Table 3](#tab3){ref-type="table"}). The mRNA expressions of*Erdj4* and *HERP* were lower both in the first and third months.

3.2. Expression of HERP and HRD1 in the Retinas of Diabetic Rats {#sec3.2}
----------------------------------------------------------------

We detected HERP and Hrd1 protein expression levels in the retinas of diabetic rats by Western blot and immunofluorescence in the first and the third months of diabetes development. The Western blot suggested that the HERP expression decreased significantly in the first month (*P* = 0.004) and third month (*P* = 0.012) compared with the nondiabetic control group. No significant change in the expression level of Hrd1 was observed in the first month (*P* = 0.338), while it decreased significantly in the third month compared with the control group (*P* = 0.001; Figures [2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}).

The results of immunofluorescence were consistent with the Western blot. The protein level of HERP decreased significantly at both the first and third months (*P* = 0.008 and 0.007, resp.; Figures [2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}). There was no significant change in the expression of retinal HRD1 in the first month, while it decreased significantly in the third month (*P* = 0.572 and 0.003, resp. Figures [2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}).

3.3. Expression of HERP and HRD1 in RRCECs in the Presence of High-Glucose Concentration {#sec3.3}
----------------------------------------------------------------------------------------

The expression levels of HERP and HRD1 in RRCECs *in vitro* in the presence of high glucose concentration were decreased significantly compared to the control group (*P* = 0.013 and 0.024, resp.; [Figure 4](#fig4){ref-type="fig"}).

4. Discussion {#sec4}
=============

The STZ-induced rat diabetes model is an established animal model for studying DR. Although we did not verify the development of DR in this study, our previous studies and the publication from another group have demonstrated that DR develops within one month of STZ-induced diabetes \[[@B13], [@B22], [@B23]\]. Our results indicate that of 89 ER stress genes, the expression of 12 genes in the retinas of diabetic rats was downregulated by the third month of diabetes development, and the expression of CCT4 increased within the first month. We did not observe any change in the expression of AFT4 or GFP78 at either time point in our study, which is consistent with our earlier results \[[@B13]\].

The expression of genes belonging to 8 different categories of ER stress factors was altered in the first month, while those of 10 categories were changed by the third month, suggesting that with increasing time more categories of ER stress factors were involved in the pathogenic process of DR. The expression of a number of related factors of the ERAD signaling pathways was downregulated, indicating that the ERAD signaling pathway may play an important role in DR. The ERAD system is an important pathway of protein degradation in the ER \[[@B25], [@B26]\] and plays important physiological roles. The ER is the location of protein synthesis, and secretion \[[@B27], [@B28]\] and has strict quality control mechanisms which allow secretion of correctly folded protein into the cytoplasm. The wrongly folded protein will be degraded through ERAD. ERAD therefore is a quality control system of the ER.

Recent studies found that HRD1 plays a central role in the ERAD-luminal pathway \[[@B29]\] and that HERP coordinates and regulates HRD1-mediated ubiquitylation \[[@B28]\], so we selected HRD1 and HERP from the ERAD pathway for further study. HERP expression was downregulated significantly in the retinas of diabetic rats in the first and third months. HERP is a membrane-bound, ubiquitin-like protein that is located in the ER. It forms a complex with ubiquitinated proteins and with the 26S proteasome \[[@B30]--[@B33]\]. HERP functions to degrade wrongly folded nonglycosylated proteins by forming a protein-enzyme complex with Derlin-1, HRD1, and p97 \[[@B34]\]. In our study, HRD1 expression in the retinas of diabetic rats remained unchanged in the first month, while it decreased in the third month. HRD1 is an E3 ubiquitin ligase and a key factor of ERAD \[[@B35]--[@B37]\]. ERAD has three pathways in yeast \[[@B38]\]: ERAD-L, ERAD-M, and ERAD-C. Both ERAD-L and ERAD-M are the key enzymes of HRD1. In the mammalian ERAD, HRD1 plays a very broad role in the ubiquitination process of abnormal proteins in the ER. The ubiquitin ligase HRD1 is mainly involved in the degradation of glycosylation proteins \[[@B39]--[@B41]\].

The decreased expression of HERP and HRD1 at both the mRNA and protein levels could lead to a decrease in function of ERAD\'s ability to remove wrongly folded proteins in the cell. Misfolded protein accumulation in the ER induces ER stress and activates signaling pathways, including PERK, ATF6, and IRE1 \[[@B15]\]. Persistent ER stress leads to cell death and induction of inflammation \[[@B42]--[@B45]\]. An inflammatory milieu is instrumental in breaking down the blood-retinal barrier in DR \[[@B46], [@B47]\].

In conclusion, we have shown by *in vivo* and *in vitro* experiments that an elevated concentration of glucose leads to downregulation of the ERAD signaling pathway. Such downregulation may result in local inflammation and DR.
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![Assessment of the expression of ER stress-related factors in diabetic retinas in the first and third months after the development of diabetes by Q-PCR arrays. (a) the histogram of the expression of different genes in 11 signaling pathways related to ER stress after the first month; (b) the histogram of the expression of different genes in 11 signaling pathways related to ER stress after the third month. Unfolded Protein Binding: UPB, ER Protein Folding Quality Control: ERPFQC, Regulation of Cholesterol Metabolism: RCM, ER-associated degradation: ERAD, Ubiquitination: Ub, Transcription Factors: TF, Protein Folding: PF, Protein Disulfide Isomerization: PDI, Heat Shock Proteins: HSP, Apoptosis: Ap°.](EDR2012-743780.001){#fig1}

![Western blot and immunofluorescence detected the expression of HERP and HRD1 in the first month after the development of diabetes: (a) Western blot detection of the expression of HERP and HRD1 in the first month. The expression of HERP in the diabetic group was less than that of the control group (*P* = 0.004); Hrd1 expression was similar in both groups (*P* = 0.338). (b) Immunofluorescence detection of the expression of HERP and HRD1 in the first month. The expression of HERP in the diabetic group was less than that of the control group (*P* = 0.008) Hrd1 expression was similar in both groups (*P* = 0.572).](EDR2012-743780.002){#fig2}

![Western blot and immunofluorescence detected the expression of HERP and Hrd1 in the third month after the development of diabetes: (a) Western blot detection of the expression of HERP and Hrd1 in the third month. The expression of HERP and Hrd1in the diabetic group was less than that of the control group (*P* = 0.012 and *P* = 0.001, resp.). (b) immunofluorescence detection of the expression of HERP and HRD1 in the third month. The expression of HERP and Hrd1 in the diabetic group was less than that of the control group (*P* = 0.007 and *P* = 0.003, resp.).](EDR2012-743780.003){#fig3}

![Immunofluorescence detection of the expression of HERP and HRD1 in RRCECs. The expression of HERP in the high glucose group was decreased compared to the control group, *P* = 0.013. The expression of HRD1 in the high glucose group was also decreased compared to the control group, *P* = 0.024.](EDR2012-743780.004){#fig4}

###### 

Q-PCR arrays showed that the expression of the ER stress factor had significant differences in the first and the third month in diabetic rat retina: The ER stress factor of differential gene expression in the first month.

  Symbol    Gene name   The average ratio of gene expression   *t*-test       
  --------- ----------- -------------------------------------- -------------- --------
  CCT4      *Cctd*      9.50E − 02                             5.90*E* − 02   0.0134
  DNAJB9    *Erdj4*     4.10E − 02                             6.20*E* − 02   0.0125
  DNAJC3    *P58IPK*    1.70E − 02                             3.00*E* − 02   0.0173
  Casp12    *Casp12*    3.20E − 04                             1.30*E* − 03   0.002
  ERP44     *Pdia10*    2.10E − 02                             2.50*E* − 02   0.0337
  GANAB     *GluII*     8.10E − 02                             1.40*E* − 01   0.045
  HERPUD1   *Herp*      1.50E − 01                             2.60*E* − 01   0.0006
  HSPA1L    *Hsp70-3*   6.30E − 04                             1.00*E* − 03   0.0183
  HSPA2     *Hspt70*    7.30E − 03                             1.30*E* − 02   0.0183
  MAPK8     *JNK*       1.10E − 02                             2.00*E* − 02   0.0391
  NUCB1     *NUC*       2.80E − 02                             5.60*E* − 02   0.0289
  OS9       *OS-9*      9.10E − 02                             1.50*E* − 01   0.0272
  SELS      *AD-015*    7.00E − 02                             9.30*E* − 02   0.0486

###### 

Q-PCR arrays showed that the expression of the ER stress factor had significant differences in the first and the third month in diabetic rat retina: The ER stress factor of differential gene expression in the third month.

  Symbol       Gene name   The average ratio of gene expression   *t*-test     
  ------------ ----------- -------------------------------------- ------------ --------
  ATF4         *CREB-2*    8.80E − 01                             1.60E + 00   0.0178
  DNAJB9       *Erdj4*     4.10E − 02                             5.40E − 02   0.0106
  ERO1L        *Ero1*      9.50E − 03                             1.20E − 02   0.0492
  TRB3         *Trib3*     5.80E − 03                             6.10E − 02   0.0024
  HERPUD1      *Herp*      7.20E − 02                             2.80E − 01   0.0008
  HTRA2        *PARK13*    2.20E − 02                             4.00E − 02   0.0064
  PPIA         *CYPA*      4.30E − 01                             6.50E − 01   0.0238
  SREBF1       *SREBP1*    2.10E − 02                             2.80E − 02   0.0187
  SYVN1/Hrd1   *HRD1*      7.90E − 02                             1.20E − 01   0.0067
  UFD1L        *UFD1*      1.60E − 01                             8.00E − 02   0.0463
  UGCGL1       *HUGT1*     9.80E − 03                             2.10E − 02   0.0833
  USP14        *TGT*       7.30E − 02                             4.80E − 02   0.0405

###### 

Q-PCR arrays showed that the expression of the ER stress factor had significant differences in the first and the third month in diabetic rat retina: the ER stress factor of significant differences belongs to different ER stress signaling pathways.

  Signaling pathway                      First month                        Third month
  -------------------------------------- ---------------------------------- ----------------------------------
  Unfolded protein binding               *Cctd, ERdj4, Hspt70-3*            *ERdj4, OMI/PARK13, CYPA, HUGT1*
  ER protein folding quality control     *GluII, PDIA10*                    *HUGT1*
  Regulation of cholesterol Metabolism   *---*                              *SREBP1*
  Regulation of translation              *---*                              *---*
  ERAD                                   *Herp, NUC, Os9, ADO15*            *Herp, OMI/PARK13, Hrd1*
  Ubiquitination                         *Herp*                             *Herp, UfD1, TGT*
  Transcription factors                  *---*                              *ATF4, SREBP1*
  Protein folding                        *Cctd, ERdj4,*   *APG-1, PDIA10*   *ERdj4, Ero1l, CYPA*
  Protein disulfide isomerization        *PDIA10*                           *SREBP1*
  Heat shock proteins                    *ERdj4, P58IPK, Hspt70-3*          *ERdj4*
  Apoptosis                              *JNK/JNK1, Casp12*                 *OMI/PARK13, NIPK/Trib3*

###### 

Q-PCR array gene table. We selected 89 ER stress-related factors, and other 6 genes as a quality control a total; of 96 genes were detected in Q-PCR arrays.

  ----- ----------- ---------------- ---------- ------------------------------------------------------------------------------------------------ -------------------------------
  A01   Rn.107561   XM_341644        AMFR       Autocrine motility factor receptor                                                               *AMFR*
  A02   Rn.161941   NM_001108183     ARMET      Arginine rich, mutated in early-stage tumors                                                     *ARMET*
  A03   Rn.2423     NM_024403        ATF4       Activating transcription factor 4 (tax-responsive enhancer element B67)                          *CREB-2/CREB2*
  A04   Rn.222130   NM_001107196     ATF6       Activating transcription factor 6                                                                *ATF6A*
  A05   Rn.18179    NM_001002809     ATF6B      Activating transcription factor 6 beta                                                           *CREB-RP/CREBL1*
  A06   Rn.42932    NM_021702        ATXN3      Ataxin 3                                                                                         *AT3/ATX3*
  A07   Rn.10668    NM_017059        BAX        BCL2-associated X protein                                                                        *BCL2L4*
  A08   Rn.974      NM_022399        CALR       Calreticulin                                                                                     *CRT/RO*
  A09   Rn.1762     NM_172008.2      CANX       Calnexin                                                                                         *CNX/IP90*
  A10   Rn.97889    NM_182814.2      CCT4       Chaperonin containing TCP1, subunit 4 (delta)                                                    *CCT-DELTA/Cctd*
  A11   Rn.62267    NM_001106603.1   CCT7       Chaperonin containing TCP1, subunit 7 (eta)                                                      *CCT-ETA/Ccth*
  A12   Rn.6479     NM_024125.4      CEBPB      CCAAT/enhancer binding protein (C/EBP), beta                                                     *C/EBP-beta*
  B01   Rn.104043   NM_001013092.1   CREB3      CAMP responsive element binding protein 3                                                        *LUMAN/LZIP*
  B02   Rn.20059    NM_001012115.1   CREB3L3    CAMP responsive element binding protein 3-like 3                                                 *CREB-H/CREBH*
  B03   Rn.11183    NM_001109986     DDIT3      DNA-damage-inducible transcript 3                                                                *CEBPZ/CHOP*
  B04   Rn.110990   NM_001014202.1   DERL1      Der1-like domain family, member 1                                                                *DER-1/DER1*
  B05   Rn.11209    NM_031627        CHOP       Rattus norvegicus nuclear receptor subfamily 1, group H, member 3                                *LXRalpha/Nr1h3*
  B06   Rn.40780    NM_001109541     DNAJB2     DnaJ (Hsp40) homolog, subfamily B, member 2                                                      *HSJ1/HSPF3*
  B07   Rn.29778    NM_012699        DNAJB9     DnaJ (Hsp40) homolog, subfamily B, member 9                                                      *DKFZp564F1862/ERdj4*
  B08   Rn.8642     NM_001106486     DNAJC10    DnaJ (Hsp40) homolog, subfamily C, member 10                                                     *DKFZp434J1813/ERdj5*
  B09   Rn.162234   NM_022232        DNAJC3     DnaJ (Hsp40) homolog, subfamily C, member 3                                                      *HP58/P58*
  B10   Rn.91398    NM_001013196     DNAJC4     DnaJ (Hsp40) homolog, subfamily C, member 4                                                      *DANJC4/HSPF2*
  B11   Rn.107459   NM_001033909     Elf2       E74-like factor 2                                                                                *Elf2*
  B12   Rn.81078    NM_130422        Casp12     Caspase 12                                                                                       *Casp12*
  C01   Rn.198593   NM_001109339     eIF2A      Eukaryotic translation initiation factor 2A, 65 kDa                                              *CDA02/EIF-2A*
  C02   Rn.24897    NM_031599        EIF2AK3    Eukaryotic translation initiation factor 2-alpha kinase 3                                        *DKFZp781H1925/HRI*
  C03   Rn.19198    NM_001037208     CRELD2     cysteine-rich with EGF-like domains 2                                                            *Creld2*
  C04   Rn.218563   XM_344959.3      ERN2       Endoplasmic reticulum to nucleus signaling 2                                                     *Ern2*
  C05   Rn.64648    NM_138528        ERO1L      ERO1-like (*S. cerevisiae*)                                                                      *Ero1l*
  C06   Rn.22325    NM_144755        TRB3       Tribbles homolog 3                                                                               *NIPK/Trib3*
  C07   Rn.2459     NM_001008317     ERP44      Thioredoxin domain containing 4 (endoplasmic reticulum)                                          *PDIA10/TXNDC4*
  C08   Rn.57325    NM_138917        FBXO6      F-box protein 6                                                                                  *FBG2/FBS2*
  C09   Rn.99241    NM_001106334     GANAB      Glucosidase, alpha; neutral AB                                                                   *G2AN/GluII*
  C10   Rn.23744    NM_001145840     GANC       Glucosidase, alpha; neutral C                                                                    *MGC138256*
  C11   Rn.4028     NM_053523        HERPUD1    Homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1   *Sup*
  C12   Rn.1950     NM_212504        HSPA1B     Heat shock 70 kDa protein 1B                                                                     *HSP70-1B/HSP70-2/Hsp72*
  D01   Rn.187184   NM_212546        HSPA1L     heat shock protein 1-like                                                                        *Hsp70-3/MGC112562/MGC114222*
  D02   Rn.211303   NM_021863        HSPA2      Heat shock protein 2                                                                             *Hspt70/Hst70/MGC93458*
  D03   Rn.163092   NM_153629        HSPA4      Heat shock protein 4                                                                             *Hsp110/ Hsp70/irp94*
  D04   Rn.144829   NM_001106428     HSPA4L     Heat shock protein 4-like                                                                        *APG-1; MGC187594; OSP94*
  D05   Rn.11088    NM_013083        HSPA5      Heat shock 70 kDa protein 5 (glucose-regulated protein, 78 kDa)                                  *BIP/GRP78*
  D06   Rn.37805    NM_001011901     HSPH1      Heat shock 105 kDa/110 kDa protein 1                                                             *DKFZp686M05240/HSP105*
  D07   Rn.107325   NM_001106599     HTRA2      HtrA serine peptidase 2                                                                          *OMI/PARK13*
  D08   Rn.163330   NM_001107321     HTRA4      HtrA serine peptidase 4                                                                          *FLJ90724*
  D09   Rn.772      NM_022392        INSIG1     Insulin-induced gene 1                                                                           *CL-6*
  D10   Rn.16736    NM_178091        INSIG2     Insulin-induced gene 2                                                                           *MGC26273*
  D11   Rn.9911     NM_012806        MAPK10     Mitogen-activated protein kinase 10                                                              *JNK3/JNK3A*
  D12   Rn.4090     XM_001056513     MAPK8      Mitogen-activated protein kinase 8                                                               *JNK/JNK1*
  E01   Rn.9910     NM_017322        MAPK9      Mitogen-activated protein kinase 9                                                               *JNK-55/JNK2*
  E02   Rn.2362     NM_053569        MBTPS1     Membrane-bound transcription factor peptidase, site 1                                            *PCSK8/S1P*
  E03   Rn.212224   NM_001035007     MBTPS2     Membrane-bound transcription factor peptidase, site 2                                            *S2P*
  E04   Rn.144645   NM_080577        NPLOC4     Nuclear protein localization 4 homolog (*S. cerevisiae*)                                         *NPL4*
  E05   Rn.1492     NM_053463        NUCB1      Nucleobindin 1                                                                                   *DKFZp686A15286/NUC*
  E06   Rn.1579     NM_001007265     OS9        Osteosarcoma amplified 9, endoplasmic reticulum associated protein                               *OS-9*
  E07   Rn.11527    NM_017319        PDIA3      Protein disulfide isomerase family A, member 3                                                   *ER60/ERp57*
  E08   Rn.7627     NM_001109476     PFDN2      Prefoldin subunit 2                                                                              *PFD2*
  E09   Rn.3401     NM_001106794     PFDN5      Prefoldin subunit 5                                                                              *MM-1/MM1*
  E10   Rn.1463     NM_017101        PPIA       Peptidylprolyl isomerase A (cyclophilin A)                                                       *CYPA/CYPH*
  E11   Rn.2232     NM_133546        PPP1R15A   Protein phosphatase 1, regulatory (inhibitor) subunit 15A                                        *GADD34*
  E12   Rn.104417   NM_001106806     PRKCSH     Protein kinase C substrate 80K-H                                                                 *AGE-R2/G19P1*
  F01   Rn.209127   NM_001127545     RNF139     Ring finger protein 139                                                                          *HRCA1/RCA1*
  F02   Rn.209127   NM_006913        RNF5       Ring finger protein 5                                                                            *RING5/RMA1*
  F03   Rn.4224     NM_013067        RPN1       Ribophorin I                                                                                     *DKFZp686B16177/OST1*
  F04   Rn.99548    NM_001100966     SCAP       SREBF chaperone                                                                                  *KIAA0199*
  F05   Rn.98327    NM_001034129     SEC62      SEC62 homolog (*S. cerevisiae*)                                                                  *Dtrp1/HTP1*
  F06   Rn.24233    NM_001107637     SEC63      SEC63 homolog (*S. cerevisiae*)                                                                  *ERdj2/PRO2507*
  F07   Rn.20802    NM_177933        SEL1L      Sel-1 suppressor of lin-12-like (*C. elegans*)                                                   *IBD2/PRO1063*
  F08   Rn.4197     NM_173120        SELS       Selenoprotein S                                                                                  *AD-015/ADO15*
  F09   Rn.2119     NM_030835        SERP1      Stress-associated endoplasmic reticulum protein 1                                                *RAMP4*
  F10   Rn.103851   NM_199376        SIL1       SIL1 homolog, endoplasmic reticulum chaperone (*S. cerevisiae*)                                  *BAP/MSS*
  F11   Rn.221929   XM_001075680     SREBF1     Sterol regulatory element binding transcription factor 1                                         *SREBP-1c/SREBP1*
  F12   Rn.41063    NM_001033694     SREBF2     Sterol regulatory element binding transcription factor 2                                         *SREBP2/bHLHd2*
  G01   Rn.162486   NM_001100739     SYVN1      Synovial apoptosis inhibitor 1, synoviolin                                                       *HRD1*
  G02   Rn.7102     NM_012670        TCP1       T-complex 1                                                                                      *CCT-alpha/CCT1*
  G03   Rn.20041    NM_153303        TOR1A      Torsin family 1, member A (torsin A)                                                             *DQ2/DYT1*
  G04   Rn.139603   NM_001106380     UBE2G2     Ubiquitin-conjugating enzyme E2G 2 (UBC7 homolog, yeast)                                         *UBC7*
  G05   Rn.106299   NM_001007655     UBE2J2     Ubiquitin-conjugating enzyme E2, J2 (UBC6 homolog, yeast)                                        *NCUBE2/PRO2121*
  G06   Rn.2022     NM_001012025     UBXN4      UBX domain protein 4                                                                             *UBXD2/UBXDC1*
  G07   Rn.11946    NM_053418        UFD1L      Ubiquitin fusion degradation 1-like (yeast)                                                      *UFD1*
  G08   Rn.162227   NM_133596        UGCGL1     UDP-glucose ceramide glucosyltransferase-like 1                                                  *HUGT1*
  G09   Rn.107678   NM_019381        BI-1       Transmembrane BAX inhibitor motif containing 6                                                   *Tmbim6*
  G10   Rn.11790    NM_001008301     USP14      Ubiquitin-specific peptidase 14 (tRNA-guanine transglycosylase)                                  *TGT*
  G11   Rn.98891    NM_053864        VCP        Valosin-containing protein                                                                       *IBMPFD/TERA*
  G12   Rn.101044   NM_001004210     XBP1       X-box binding protein 1                                                                          *TREB5/XBP2*
  H01   Rn.973      NM_001007604     Rplp1      Ribosomal protein, large, P1                                                                     *MGC72935*
  H02   Rn.47       NM_012583        Hprt       Hypoxanthine guanine phosphoribosyl transferase                                                  *Hgprtase/Hprt1*
  H03   Rn.92211    NM_173340        Rpl13a     Ribosomal protein L13A                                                                           *Rpl13a*
  H04   Rn.107896   NM_017025        Ldha       Lactate dehydrogenase A                                                                          *Ldh1*
  H05   Rn.94978    NM_031144        Actb       Actin, beta                                                                                      *Actx*
  H06   N/A         U26919           RGDC       Rat genomic DNA contamination                                                                    *RGDC*
  H07   N/A         SA_00104         RTC        Reverse Transcription Control                                                                    *RTC*
  H08   N/A         SA_00104         RTC        Reverse transcription control                                                                    *RTC*
  H09   N/A         SA_00104         RTC        Reverse transcription control                                                                    *RTC*
  H10   N/A         SA_00103         PPC        Positive PCR control                                                                             *PPC*
  H11   N/A         SA_00103         PPC        Positive PCR control                                                                             *PPC*
  H12   N/A         SA_00103         PPC        Positive PCR control                                                                             *PPC*
  ----- ----------- ---------------- ---------- ------------------------------------------------------------------------------------------------ -------------------------------
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